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INTRODUCTION
 
There has been an increasing recognition over the past several 
years that dietary lipids can play important roles in metabolism and 
signaling in addition to their classical role as a source of energy 
(e.g. Jump and Clarke, 1999; Chong and Marx, 2001). One example of a 
family of lipids that has been implicated in modulating such divergent 
processes as cancer development, lipid metabolism, bone mineralization 
and others are conjugated linoleic acids, or CLA. 
The interest in CLA really began with an attempt by Pariza and 
coworkers to identify carcinogenic compounds in cooked beef· (reviewed
aby Pariza, .1999). Ironically, this project instead identified 
compound with very potent anti-cancer properties that was finally 
identified as cis-9, trans-11 CLA. Parodi (1977) had identified this 
compound several years prior as a component of cow's milk, and it is 
now clear that ruminant fat depots are the most abundant natural source 
of this fatty acid. Subsequent studies performed by Ip and coworkers 
(1991; 1999) elegantly demonstrated that CLA is a potent anti carcinogen 
in mouse models of mammary cancer and others have demonstrated these 
anticarcinogenic properties in many other models (reviewed by Pariza, 
1999) . 
CLA are actually a family of related fatty acid forms, or 
isomers, each with apparently divergent biological activities. The 
structural differences lie in the arrangement of the two carbon-carbon 
double bonds within the molecule, each isomer having a unique 
combination of position (9, 10, 11, 12, etc.) and geometry (cis- or 
trans-; Figure 1). There are two isomers of CLA that have received the 
greatest attention in scientific investigations, cis-9, trans-11 CLA 
~nd trans-10, cis-12 CLA, each formed by the isomerization of the cis­-
12 or cis-9 double-bonds of linoleic acid, respectively (Figure 1). 
Figure 1. Structure of 
linoleic acid and two cOC"Jllon 
CLA isomers. Arrows indicate 
the position of carbon-carbon 
double bonds. 
linoleic acid (cis-g. cls-12) cis-g. trans-11 CLA trans·10, cls-12 CiA 
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The cis-9, trans-11 isomer is implicated in the anti-cancer properties 
of. CLA while the trans-10, cis-12 isomer is generally associated ...lith 
effects on lipid metabolism in models of lactation as well as adipose 
and liver metabolism. Both of these fatty acids naturally occur in 
ruminant lipids due to their production in the microbial process of 
biohydrogenation of linoleic acid in the rumen. While cis-9, trans-l1 
CLA is the predominant CLA isomer in the milk and body fat of 
ruminants, trans-10, cis-12 CLA is but one of more than a dozen other 
isomers that occur .i.n trace amounts in ruminant fat (Sehat et al., 
1998; Fritsche et al., 2000). 
CLA ENRICHMENT OF MILK FAT 
Rumen microbes are responsible for the alteration of many dietary 
components; indeed, without their fermentation of plant matter, the 
ruminant would not survive: One alteration that is of paramount 
interest in regard to understanding CLA is the process of 
biohydrogenation of polyunsaturated fatty. acids (PUFA) , or the 
reduction of PUFA to saturated fatty acids (SFA). Intermediates in the 
pathways of biohydrogenation include CLA isomers, as well as related 
fatty acids that contribute to the CLA content of ruminant fat. It is 
ironic that the same pro~ess that is responsible for the relatively 
high saturated fat content of ruminant-derived foods, a characteristic 
of fat generally considered to be unhealthy, is also responsible for. 
the formation of CLA, a fatty acid that may have health benefits. 
Early work characterizing the process of rumen biohydrogenation 
established 
1970; 
the 
18:1 
the 
that Cis-9, trans-1l CLA was an intermediate in the
 
biohydrogenation of linoleic acid to stearic acid (Dawson· and Kemp,
 
Keeney, 1970; Harfoot 1978). The cis-9, trans-l1 isomer of CLA is
 
most abundant in ruminant tissues and food products derived from
 
ruminants due in large part to its potential to be synthesized
 
. endogenously from another rumen biohydrogenation intermediate, trans-l1
 
(Bauman et al., 2003). This process is carried out by the enzyme 
stearoyl CoA desaturase (SCD) that introduces a cis-9 double bond in 
trans-11 18:1 intermediate, forming cis-9, trans-11 CLA (Figure 2)'. 
Rumen Tissues 
Linolenic acid Linoleic acid 
cis-9, cis·12, ds-15 18:3 cis-9, cis-1218:2 
~ ~
cis-9, trans-11, cis-15 18:3 cis-9, trans-11 CLA .... ,. cis-9, trans-11 CLA 
~ 1Stearoyl CoA 
Desaturase!trans-11. cis-1518:2  ........... 

........... 
trans-11 18:1 -,. trans-1118:1 
~
18:0 
Figure 2. Pathways for ruminal biohydrogenation and endogenous synthesis of cis-g. 
trans-ll CLA. Pathways for biohydrogenation of linolenic and linoleic acids yielding 
trans-ll 18: 1 are shown in the rumen box and endogenous synthesis by stearoyl CoA 
desaturase is shown in the tissues bbx. Figure adapted from Bauman et al. (2003). 
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Estimates of the contribution of endogenous synthesis range from 60% 
and 90% of the CLA in milk fat (Griinari et al., 2000; Corl et al., 
2001; Kay et al., 2002). Even though SCD converts a portion of the 
cow's trans-11 18:1 to CLA in the mammary gland, the amount of trans-11 
18: 1 in milk fat is generally about 3 -fold greater than the amount of 
CLA. This is important because animals (including humans) consuming 
cow's milk also have the SCD enzyme used to endogenously synthesize 
CLA. In a particularly notable cancer study, Ip et al. (1999) 
demonstrated that CLA-enriched butter produced by feeding cows to 
promote CLA- synthesis is perhaps even more effective against cancer 
than purified cis-9, trans-11 CLA. This was postulated to be due to 
the presence of trans-11 18: 1 in the lipid that can be converted to 
cis-9, trans-11 CLA in tissues (Ip et al., 1999). It has since been 
demonstrated that this conversion of trans-11 18: 1 contributes 
significantly to the cancer-fighting properties of natural CLA-enriched 
milk fat (Corl et al., '2003). 
Dietary factors that affect the CLA content of milk fat' include 
addition of biohydrogenation substrates such as linoleic and linolenic 
acids, and modification of the rumen environment to promote incomplete 
biohydrogenation (see reviews by Griinari and Bauman, 1999; Bauman et 
al., 2001). Most attempts to elevate milk fat CLA content result in 
variable degrees of success depending on the individual; while one 
animal may respond very well, another may have little to no response. 
In an attempt to further characterize the nature of this variation, we 
conducted a study involving 3 groups of animals (n=lO/group); one was 
fed a standard TMR, one fed a diet designed to enhance milk fat CLA, 
and one group was s""itched between these diets at 3 week intervals 
(Peterson et al., 2002b). Our diet designed, to elevate mllk fat CLA 
content employed full-fat extruded soybeans and led to a significant 
increase in milk fat content of ciS-9, trans-11 CLA. Interestingly, 
when the responses of animals in the alternating diet group were 
considered individually, it was noted that animals varied 2- to 3-fold 
in their response, and that the hierarchy among' animals remained 
largely constant across dietary shifts (see figure 3). The data from 
this stUdy indicated that while diet has a major influence on the milk 
fat content of CLA, individual animal differences also have a 
substantial effect. This animal-specific effect likely involves the 
seD enzyme that is critical to the endogenous synthesis of CLA from 
trans-11 18:1. Because of the importance of this enzyme in the 
synthesis of cis-9, trans-11 CLA, current research both in the us and 
worldwide is focused on identifying variation in the SCD gene that 'may 
be used for animal selection. 
14,------------------, 
Figure 3. Temporal12 
pattern in the
-en individual hierarchy in 
milk fat CIA for cows:5 ~ 10 
alternated between au IV 
>. standard diet (periods 
.... ~ 8
::.e 1 and 31 and a diet designed to elevate
mel milk fat CIA (periods 2 
u C, 6 
and 41. The duration 
-
E
4 
of each period was 3 
weeks. Figure from 
Peterson et al. 
(2002bl.
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CLA AND MILK FAT DEPRESSION 
Milk fat content and composition can be impacted by many factors, 
and one example is the low-fat milk syndrome, also referred to as milk 
fat depression (MFD). In this situation, cows fed diets high in 
readily fermentable carbohydrates and low in effective fiber, or diets 
containing supplements of polyunsaturated oils of either plant or fish 
origin exhibit a dramatic and' specific reduction in the secretion of 
milk fat. These diets can reduce milk fat by up to 50% without any 
effect on other aspects of lactation, and this reduction is quickly 
rescued when the dietary treatment is removed (reviewed by Bauman and, 
Griinari, 2001; Bauman et al., 2003). Boussingault was the first to 
document MFD in an 1845 report of a reduction in milk fat secretion,in 
response to feeding cows a diet containing beets (cited by Van Soest, 
1994) . Again in 1926, when Golding and coworkers (1926) were 
attempting to manipulate the fat-soluble vitamin content of milk, they 
observed a precipitous decline in milk fat secretion when cows were fed 
a diet containing cod liver oil. Ever since these observations, 
investigators have sought to determine the mechanism behind this 
phenomenon with little success-until recently. 
Early attempts at enhancing the content of ciS-9, trans-11 CLA in 
milk fat included simply supplying chemically synthesized CLA isomers 
postruminally to lactating dairy cows. It was quickly observed that 
these treatments led to a precipitous decline in milk fat yield (Loor 
and Herbein, 1998; Chouinard et al., 1999a; 1999b) which is also the 
hallmark of the 150 year-old MFD phenomenon. This activity was 
subsequently attributed to the trans-10, cis-12 CLA isomer, and we have 
established a dose-response relationship demonstrating the extreme 
potency of this compound in inhibiting milk fat synthesis (Figure 4; 
Baumgard et al.; 2000; 2001; Peterson et al., 2002a). 
0
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~ Figure 4. Relationship
>. y =O.24x2 - 6.99x between the decrease in
... ·10 R2 =0.99 milk fat yield and dose
.ll! 
x. of trans-lO, cis-li c~
E -20 abomasally infused into lactating dairy cows . 
.~
III All values represent the
·30III mean (n=4) decrease after 
.. 
III 
llJ 5 days of infusion at the 
u indicated dose. Figure
-40
-8 from Peterson et al. 
... (2002a) •c 
II) ·50 
u
.. 
ell Q. 
·60
  
0 5 10 15
 
trans-10, ds-12 eLA dose (g/d) 
Based in part on these observations, Bauman and   
proposed that MFD diets cause alterations in the   
pathways leading to the production of alternative 
Griinari (2001) 
biohydrogenation 
fatty acid 
fatty acids can then intermediates such as trans-lO, cis-12 CLA. These   
be absorbed in small quantities, and act to inhibit lipid synthesis in   
the mammary gland. Subsequent studies revealed that diet-induced MFD 
led to increases in the abundance of trans-lO, ~iS-12 CLA in milk fat   
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that were correlated with reductions in the activity of genes involved 
in lipid synthesis in the mammary gland (Peterson et al., 2003). 
Additionally, the reductions in gene expression observed during diet­-
induced MFD were very similar to those observed during MFD induced by 
CLA administration (Baumgard et al., 2002). These data support the 
biohydrogenation theory as a unifying explanation for diet-induced milk 
fat depression. 
Our understanding of the anti-lipogenic properties of trans-10, 
cis-12 CLA has also provided a potentially valuable management tool. 
Fat is the primary energy component in milk, and therefore comprl·ses 
the greatest metabolic burden on a lactating animal. The strategic 
inhibition of milk fat synthesis can be used to relieve metabolic 
strain during times of nutrient insufficiency such as the onset of 
lactation when intake lags behind nutrient demand, or when adequate 
nutrients are not available as can occur at times, in a pasture-based 
system. Additionally, CLA can be used to alter milk composition to 
better match market demands such as in areas where milk fat quotas are 
employed. 
CONCLUSIONS 
Conjugated linoleic acids are potent compounds that naturally 
occur in ruminant fats such as milk fat. The most abundant CLA isomer 
in milk fat is cis-9, trans-11 and has been sho\~ to possess potent 
anti-cancer activities. Also important is endogenous synthesis of this 
fatty acid from trans-11 18:1 via the SCD enzyme both in terms of CLA 
enrichment of milk fat as well as in terms of the cancer fighting 
effects in the consumer. It is likely that the' animal-to-ani~al
variation in milk fat CLA content is due to intrinsic factors such as 
SCD. The trans-10, cis-12 isomer of CLA is produced in the rumen under 
certain dietary conditions and is a potent inhibitor of milk fat 
synthesis. In addition to being implicated in the condition known as 
milk fat depression, this CLA isomer has potential for managing milk 
fat synthesis to improve animal health in response to metabolic 
challenges, or to match production markets. 
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